Aug. 19, 2025 — According to the latest study from BCC Research, the "Global Mammography Equipment Markets" is projected to grow from $3.1 billion in 2025 to $4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 5.2% from 2025 through 2030.

This report provides a detailed review of the global mammography equipment market, highlighting current technologies, growth drivers and emerging opportunities. The report segments by equipment type, end-user industry, and region.

Aug. 19, 2025 — Calidar, Inc., a start-up in precision diagnostic imaging formed out of Duke University, recently announced the successful imaging of the first patient with its 4D Mammography system. The next-generation imaging system harnesses X-ray diffraction and AI to measure novel molecular-level signals of disease, offering the potential to significantly improve diagnostic accuracy.

Aug. 12, 2025 — MARS Bioimaging has appointed of Dr. Ojas Mahapatra as Group Chief Executive Officer. Mahapatra is an accomplished executive with more than a decade of experience scaling and transforming deep-tech companies in global markets. Mahapatra most recently was CEO of New Zealand cleantech company Fabrum.

Aug. 13, 2025 — A new study from Denmark shows for the first time that men with biochemically recurrent prostate cancer who undergo PSMA PET/CT before salvage radiotherapy have improved survival rates compared to those who do not. Using data collected nationwide over a period of eight years, researchers confirmed that PSMA PET/CT is a valuable tool for identifying patients who are likely to benefit from salvage radiotherapy. This research was published in the August issue of The Journal of Nuclear Medicine.

Aug. 13, 2025 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, recently announced that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for ArteraAI Prostate, establishing it as the first and only AI-powered software authorized to prognosticate long-term outcomes for patients with non-metastatic prostate cancer.

Aug. 12, 2025 —Sonic Incytes Medical Corp, has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Velacur ONE, its point-of-care ultrasound elastography device. Building on the success of its original model, Velacur, Velacur ONE introduces an enhanced interface and features for improved portability and user experience. These improvements enable broader scalability to support Sonic Incytes’ accelerated US and global expansion strategy.

Aug. 14, 2025 — Philips has announced a plan for new investments of more than $150 million in U.S. manufacturing and research and development (R&D).  Philips also unveiled the expansion of its Reedsville, PA, manufacturing facility, which produces AI-enabled ultrasound systems for hospitals across the U.S.

Aug. 14, 2025 —  An interventional radiologist at NYU Langone Health recently performed a procedure to relieve a patient's chronic knee pain caused by osteoarthritis. The procedure was performed in less than two hours while the patient was mildly sedated.

Aug. 13, 2025 — Registration is now open for the RSNA 111th Scientific Assembly and Annual Meeting, the world’s leading annual radiology forum.

The meeting will take place Nov. 30-Dec. 4, in Chicago at McCormick Place.

Aug. 13, 2025 — Ultrasound AI has published the latest findings from its PAIR (Perinatal Artificial Intelligence in Ultrasound) Study in The Journal of Maternal-Fetal & Neonatal Medicine. The study was performed in collaboration with researchers at the University of Kentucky and validates Ultrasound AI's proprietary technology that more accurately predicts time to delivery using only standard ultrasound images.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now